FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
For FDA Voices older than 2023, please view the archived page.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Good Clinical Practices Are Not Optional: The FDA’s Commitment to Human Subject Protections and Gold Standard Science in an Era of Global Clinical Research
The FDA’s position is clear: GCP is not bureaucratic formality. It is the scientific and ethical foundation on which our regulatory decisions rest.
FDA Weighs in on the Development and Use of Digitally Derived Measures for Clinical Investigations
Unlocking the Full Potential of Digital Health Technologies to Support Medical Product Development and Innovation
Some table information
| Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
|---|